Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013

Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May
                                   9, 2013

Conference Call and Webcast to Follow

PR Newswire

WASHINGTON, April 18, 2013

WASHINGTON, April 18, 2013 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda)
(NASDAQ: VNDA), a biopharmaceutical company focused on the development and
commercialization of products for the treatment of central nervous system
disorders, today announced it will release results for the first quarter of
2013 on Thursday, May 9, 2013, before the market opens.

The Company will host a conference call at 10:00 AM ET on Thursday, May 9,
2013, during which Vanda management will discuss the financial results. To
participate in the conference call, please dial 1-877-280-4962 (domestic) or
1-857-244-7319 (international) and use passcode 32610810.

The conference call will be broadcast simultaneously and archived on the
Company's website, www.vandapharma.com. Investors should go to the website at
least 15 minutes early to register, download, and install any necessary audio
software.

A replay of the call will be available on Thursday, May 9, 2013, beginning at
12:00 PM ET and will be accessible until Thursday, May 16, 2013, at 5:00 PM
ET. The replay call-in number is 1-888-286-8010 for domestic callers and
1-617-801-6888 for international callers. The passcode number is 47460221.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the
development and commercialization of products for the treatment of central
nervous system disorders. For more on Vanda Pharmaceuticals Inc., please
visit www.vandapharma.com.

Company
Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.

Website: http://www.vandapharma.com
 
Press spacebar to pause and continue. Press esc to stop.